All Mergers and acquisitions articles – Page 7
-
BusinessPfizer gambles on $14bn Medivation deal
Cancer specialist likely just one target in hunt for marketed drugs to offset patent expiries
-
BusinessEU examines Dow–DuPont union
European commission probes competition implications of the planned mega-merger
-
BusinessUS government sued over merger crackdown
Business groups challenge Obama’s steps to limit tax inversions
-
BusinessAmgen and Advaxis partner on immuno-oncology
Deal covers rights to system for building cancer therapies specific to a patient’s own tumours
-
BusinessArkema boosts Bostik adhesives
New adhesives plant in Sweden and acquisition of Dutch firm Den Braven
-
BusinessCelgene and Jounce team up against cancer
Firms promise next-generation immuno-oncology as existing drugs rack up successes
-
BusinessHenkel to buy detergent maker Sun Products
€3.2bn deal boosts Henkel’s position in North American laundry care market
-
BusinessAstraZeneca licenses skin drugs to Leo
Offloading psoriasis and dermatitis antibodies continues AZ’s plan to refocus on fewer therapy areas
-
BusinessNovartis partners with Xencor for cancer antibodies
Deal deepens Novartis’s focus on immuno-oncology
-
BusinessSanofi and Boehringer agree €11bn asset swap
Deal swaps Sanofi’s animal health arm for Boehringer’s consumer healthcare business as both firms aim to boost scale
-
Business
Teva sells off products in preparation for Allergan merger
Generics deals with Impax, Dr Reddy’s and Sagent aimed at satisfying competition authorities
-
BusinessBASF boosts coatings with Chemetall buyout
$3.2bn purchase from Albemarle continues BASF’s efforts to expand and refocus its coatings division
-
BusinessWestlake Chemical to buy rival Axiall
US chemical manufacturer Axiall acquired by Westlake Chemical for $3.8 billion, after its earlier bid was rejected
-
Business
Merck & Co to buy Afferent for neurology drugs
Deal worth up to $1.25bn includes drug candidate for chronic coughs
-
BusinessJ&J to buy Vogue for haircare range
$3.3bn deal expands Johnson & Johnson’s consumer products segment
-
BusinessThermoFisher Scientific to buy electron microscope maker
Deal will expand lab equipment provider’s instrument portfolio for life and materials sciences
-
BusinessJazz Pharma buy out Celator in $1.5bn deal
Deal centres on promising leukaemia drug fast-tracked by the US Food and Drug Administration
-
BusinessUS tax rules force fertiliser merger to fall flat
CF Industries’ $8bn merger plan to relocate from US to Europe scuppered by regulatory changes
-
BusinessMonsanto turns down Bayer offer
As global agrochemical companies consolidate, Monsanto rejects ‘inadequate’ $62bn offer from Bayer
-
BusinessMylan expands in dermatology
$1bn deal with Renaissance Acquisition Holdings brings 25 products and builds on Meda merger portfolio